Cochrane Evidence Synthesis and Methods ►

Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of FLT3 TKIs as maintenance therapy compared to no maintenance therapy or alternative strategies for participants with FLT3-mutated AML after allo-HSCT.

This is a protocol.

Published:

28 April 2025

Authors:

Chen PH, Jhou HJ, Lee CH

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Chen PH, Jhou HJ, Lee CH. Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia (Protocol). Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD016090. DOI: 10.1002/14651858.CD016090.